Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scienion and Genomica Expand Collaboration

Published: Wednesday, November 07, 2012
Last Updated: Wednesday, November 07, 2012
Bookmark and Share
Both companies will offer to the life science market a jointly developed new printing plate technology platform.

This new platform combines Scienion's non-contact arraying and surface technologies with Genomica's multiplex PCR technology and microarrays detection. Both enterprises will advance in the development of new molecular applications, among which, in vitro diagnostics and personalized medicine will lead the way.

Berlin, Germany, and Madrid, Spain, November 5, 2012: Dr. Holger Eickhoff, CEO of Scienion AG, stated: “The technologies of our companies optimally complement one another. Genomica has an excellent track record of successfully marketed DNA-based IVD tests and with its CLART® technology products the company is considered a benchmark in molecular diagnostics. Combining this expertise with Scienion’s state of the art non-contact dispensing technology, our consumables such as high quality microtiter plates and our production capabilities adds up to a perfect match. We are aiming to speed up the development of better and safer in vitro diagnostics and will offer joint technology solutions for the benefit of users and last but not least also for patients.”

Dr. Rosario Cospedal, CEO of Genomica S.A.Unipersonal, added: “Both companies meet the highest quality standards in the development, manufacturing and commercialization of their products. Genomica has a highly competitive technology based on multiplex PCR and microarrays detection. The ability of this technology to detect specific targets with high sensitivity and specificity has allowed our company to expand its market and be competitive in the molecular diagnostics field. Our existing collaboration with Scienion, a trustable and expert company in non-contact printing technology, has already proved to be a good partnership. The close and constructive cooperation between both companies is making possible to identify more subareas for joint activities and we move forward to tap the full potential”.

Based on this new printing plate technology, Scienion and Genomica will jointly offer new services for customers in the microarrays life science industry. These services range from assay development to manufacturing of microarrays individually tailored to the needs and specifications of customers.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIENION and Anteo Partner
Partnership to develop consumables for better functionality and longer shelf life of protein microarrays.
Saturday, July 25, 2015
QuantuMDx and SCIENION Partner to Commercialize Novel Nanowire Biosensor
This biosensor is a component of QMDx's flagship product Q-POC™, a handheld molecular diagnostic device that will provide results in 15 minutes for a few pounds at the patient's side.
Tuesday, June 09, 2015
SCIENION US, Inc. Receives ISO 13485 Certification
An internationally recognized standard for quality management systems (QMS).
Friday, March 20, 2015
Scienion to Partner with Maine Manufacturing
The non-exclusive distribution arrangement includes the worldwide marketing of the complete FAST® Slide product line.
Monday, September 10, 2012
SCIENION Founded US Subsidiary
Expansion in the North American market planned.
Monday, December 12, 2011
Positive Feedback on Scienion’s Unique Workshop on the IVD Value Chain
“From Sample to Assay – From R&D to IVD” was the title of a two-day workshop Scienion AG hosted in Berlin recently. Almost 100 participants from 12 countries benefited from an outstanding program.
Wednesday, November 03, 2010
Scienion Receives ISO 9001:2008 Certification
Company claims to be one the first biotech companies to be certified according to the latest revision of the standard for quality management systems.
Thursday, February 19, 2009
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!